These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 36357676)

  • 21. High-dimensional characterization of post-acute sequelae of COVID-19.
    Al-Aly Z; Xie Y; Bowe B
    Nature; 2021 Jun; 594(7862):259-264. PubMed ID: 33887749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risks of mental health outcomes in people with covid-19: cohort study.
    Xie Y; Xu E; Al-Aly Z
    BMJ; 2022 Feb; 376():e068993. PubMed ID: 35172971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine : A Retrospective Cohort Study.
    Gazit S; Shlezinger R; Perez G; Lotan R; Peretz A; Ben-Tov A; Herzel E; Alapi H; Cohen D; Muhsen K; Chodick G; Patalon T
    Ann Intern Med; 2022 May; 175(5):674-681. PubMed ID: 35157493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiological assessment of SARS-CoV-2 reinfection.
    Almadhi M; Alsayyad AS; Conroy R; Atkin S; Awadhi AA; Al-Tawfiq JA; AlQahtani M
    Int J Infect Dis; 2022 Oct; 123():9-16. PubMed ID: 35931371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Hope AA; Evering TH
    Infect Dis Clin North Am; 2022 Jun; 36(2):379-395. PubMed ID: 35636906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection.
    Murillo-Zamora E; Mendoza-Cano O; Delgado-Enciso I; Hernandez-Suarez CM
    Public Health; 2021 Apr; 193():113-115. PubMed ID: 33774512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between malnutrition and post-acute COVID-19 sequelae: A retrospective cohort study.
    Ponce J; Anzalone AJ; Schissel M; Bailey K; Sayles H; Timmerman M; Jackson M; Tefft J; Hanson C;
    JPEN J Parenter Enteral Nutr; 2024 Jun; ():. PubMed ID: 38924100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.
    Petrie JG; Bazzi LA; McDermott AB; Follmann D; Esposito D; Hatcher C; Mateja A; Narpala SR; O'Connell SE; Martin ET; Monto AS
    J Infect Dis; 2021 Jul; 224(1):49-59. PubMed ID: 33755731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative outcomes of SARS-CoV-2 primary and reinfection in older adult patients.
    Tey SF; Tsai YW; Wu JY; Liu TH; Chuang MH; Hsu WH; Huang PY; Lai CC; Hsu CK
    Front Public Health; 2024; 12():1337646. PubMed ID: 38435287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study.
    Leidi A; Koegler F; Dumont R; Dubos R; Zaballa ME; Piumatti G; Coen M; Berner A; Darbellay Farhoumand P; Vetter P; Vuilleumier N; Kaiser L; Courvoisier D; Azman AS; Guessous I; Stringhini S;
    Clin Infect Dis; 2022 Mar; 74(4):622-629. PubMed ID: 34043763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence of SARS-CoV-2 symptomatic reinfection in four healthcare professionals from the same hospital despite the presence of antibodies.
    Gargouri S; Souissi A; Abid N; Chtourou A; Feki-Berrajah L; Karray R; Kossentini H; Ben Ayed I; Abdelmoula F; Chakroun O; Nasri A; Hammami A; Rekik N; Masmoudi S; Karray-Hakim H; Rebai A
    Int J Infect Dis; 2022 Apr; 117():146-154. PubMed ID: 35017107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness Associated With Vaccination After COVID-19 Recovery in Preventing Reinfection.
    Lewis N; Chambers LC; Chu HT; Fortnam T; De Vito R; Gargano LM; Chan PA; McDonald J; Hogan JW
    JAMA Netw Open; 2022 Jul; 5(7):e2223917. PubMed ID: 35895058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study.
    Cohen K; Ren S; Heath K; Dasmariñas MC; Jubilo KG; Guo Y; Lipsitch M; Daugherty SE
    BMJ; 2022 Feb; 376():e068414. PubMed ID: 35140117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients Undergoing Serial Laboratory Testing.
    Qureshi AI; Baskett WI; Huang W; Lobanova I; Hasan Naqvi S; Shyu CR
    Clin Infect Dis; 2022 Jan; 74(2):294-300. PubMed ID: 33895814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 reinfection after previous infection and vaccine breakthrough infection through the second wave of pandemic in India: An observational study.
    Dhumal S; Patil A; More A; Kamtalwar S; Joshi A; Gokarn A; Mirgh S; Thatikonda P; Bhat P; Murthy V; Chavan P; Oak A; Gore S; Bhattacharjee A; Patkar N; Kannan S; Shetty N; Rawat A; Achrekar M; Trivedi B; Laskar S; Chaturvedi P; Badwe R; Khattry N; Gupta S
    Int J Infect Dis; 2022 May; 118():95-103. PubMed ID: 35192951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modifiable lifestyle factors and the risk of post-COVID-19 multisystem sequelae, hospitalization, and death.
    Wang Y; Su B; Alcalde-Herraiz M; Barclay NL; Tian Y; Li C; Wareham NJ; Paredes R; Xie J; Prieto-Alhambra D
    Nat Commun; 2024 Jul; 15(1):6363. PubMed ID: 39075060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections.
    Taquet M; Dercon Q; Harrison PJ
    Brain Behav Immun; 2022 Jul; 103():154-162. PubMed ID: 35447302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rates and Factors Associated With Documentation of Diagnostic Codes for Long COVID in the National Veterans Affairs Health Care System.
    Ioannou GN; Baraff A; Fox A; Shahoumian T; Hickok A; O'Hare AM; Bohnert ASB; Boyko EJ; Maciejewski ML; Bowling CB; Viglianti E; Iwashyna TJ; Hynes DM
    JAMA Netw Open; 2022 Jul; 5(7):e2224359. PubMed ID: 35904783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study.
    Townsend JP; Hassler HB; Wang Z; Miura S; Singh J; Kumar S; Ruddle NH; Galvani AP; Dornburg A
    Lancet Microbe; 2021 Dec; 2(12):e666-e675. PubMed ID: 34632431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nationwide study of rates of reinfection with SARS-CoV-2 among adults in Kuwait.
    Al-Ahmad M; Alowayesh M; Al Awadi A; Alghounaim M; Al Hashemi H; Al Enezi L; Rawdhan H; Rodriguez-Bouza T
    East Mediterr Health J; 2023 Feb; 29(2):146-150. PubMed ID: 36880496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.